CL Financials Colgate-Palmolive

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Nov 1, 2026, 10:30 UTC Overview →

Growth & profitability

Revenue has grown 4.4% per year over the past 5 years.
Net income has grown slower than revenue (-4.6% vs 4.4% per year).
Operating margin has contracted, at 16.2% in the latest year.
Free cash flow has grown 1.9% per year over the past 5 years.

Financial health

Total debt ($7.8B) exceeds cash ($1.3B); net debt is $6.6B.
Total debt has grown slower than revenue (1.3% vs 4.4% per year).
Operating income covered interest expense 12× in the latest year.
Total debt is 2.0× EBITDA.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$20.4B	$2.1B	60.1%	16.2%	3948.1%	13.1%	$3.6B	$7.8B	$1.3B
2024	$20.1B	$2.9B	60.5%	21.2%	1362.7%	18.0%	$3.5B	$7.0B	$1.1B
2023	$19.5B	$2.3B	58.2%	20.5%	377.7%	14.0%	$3.0B	$8.2B	$966M
2022	$18.0B	$1.8B	57.0%	16.1%	445.1%	11.3%	$1.9B	$8.8B	$775M
2021	$17.4B	$2.2B	59.6%	19.1%	355.7%	14.4%	$2.8B	$7.2B	$832M
2020	$16.5B	$2.7B	60.8%	23.6%	362.7%	16.9%	$3.3B	$7.3B	$888M
2019	$15.7B	$2.4B	59.4%	22.6%	2023.1%	15.7%	$2.8B	$7.6B	$883M
2018	$15.5B	$2.4B	59.4%	23.8%	-2352.9%	19.7%	$2.6B	$6.4B	$726M
2017	$15.5B	$2.0B	60.0%	24.0%	-3373.3%	16.0%	$2.5B	$6.6B	$1.5B
2016	$15.2B	$2.4B	60.0%	26.0%	-1004.5%	20.1%	$2.5B	$6.5B	$1.3B
2015	—	$1.4B	—	—	-462.9%	11.6%	$2.3B	$6.5B	$970M
2014	—	$2.2B	—	—	190.4%	16.2%	$2.5B	$6.1B	$1.1B
2013	—	$2.2B	—	—	97.2%	16.0%	$2.5B	$5.6B	$962M
2012	—	$2.5B	—	—	112.9%	18.5%	$2.6B	$5.2B	$884M
2011	—	$2.4B	—	—	102.4%	19.1%	$2.4B	$4.8B	$878M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Sep '26	$5.4B	$751M	60.2%	20.3%	260.8%	4.5%	$1.0B	$7.2B	$1.5B
Jun '26	$5.4B	$693M	61.5%	19.0%	293.6%	4.1%	$867M	$7.8B	$1.4B
Mar '26	$5.3B	$646M	60.6%	18.1%	445.5%	3.9%	$609M	$7.9B	$1.3B
Dec '25	$5.2B	-$37M	60.2%	1.8%	-68.5%	-0.2%	$1.3B	$7.8B	$1.3B
Sep '25	$5.1B	$735M	59.4%	20.6%	85.9%	4.2%	$1.1B	$7.3B	$1.3B
Jun '25	$5.1B	$743M	60.1%	21.1%	105.8%	4.3%	$776M	$7.1B	$1.2B
Mar '25	$4.9B	$690M	60.8%	21.9%	190.1%	4.1%	$476M	$8.3B	$1.1B
Dec '24	$4.9B	$739M	60.3%	21.5%	348.6%	4.6%	$1.1B	$7.0B	$1.1B
Sep '24	$5.0B	$737M	61.1%	21.2%	169.4%	4.4%	$1.0B	$7.9B	$1.2B
Jun '24	$5.1B	$731M	60.6%	21.6%	594.3%	4.4%	$873M	$8.2B	$1.1B
Mar '24	$5.1B	$683M	60.0%	20.7%	297.0%	4.1%	$555M	$8.2B	$1.1B
Dec '23	$5.0B	$718M	59.6%	21.7%	117.9%	4.4%	$939M	$8.2B	$966M
Sep '23	$4.9B	$708M	58.5%	20.9%	-7866.7%	4.4%	$991M	$8.7B	$951M
Jun '23	$4.8B	$502M	57.8%	20.2%	-784.4%	3.1%	$538M	$9.0B	$819M
Mar '23	$4.8B	$372M	56.9%	19.1%	-6200.0%	2.3%	$572M	$8.9B	$867M
Dec '22	$4.6B	$5M	55.6%	4.4%	1.2%	0.0%	$452M	$8.8B	$775M
Sep '22	$4.5B	$618M	57.2%	21.3%	99.4%	3.8%	$794M	$8.2B	$938M
Jun '22	$4.5B	$603M	57.0%	19.7%	358.9%	3.8%	$350M	$8.0B	$858M
Mar '22	$4.4B	$559M	58.5%	19.5%	174.1%	3.6%	$264M	$7.6B	$877M
Dec '21	$4.4B	$148M	58.1%	8.3%	24.3%	1.0%	$913M	$7.2B	$832M

Valuation over time

How the market has priced CL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 33.5× (Mar '23) to 36.3× (Nov '26).
The price-to-sales ratio has risen from 3.3× (Mar '23) to 3.8× (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Frequently asked questions

Is CL growing its revenue and profit?

Over the past 5 years, Colgate-Palmolive's revenue has grown 4.4% per year, and net income declined 4.6% per year. These are computed facts, not advice.

How much debt does CL have?

As of FY2025, Colgate-Palmolive reported $7.8B of total debt against $1.3B of cash; operating income covered interest expense 12×.

What is CL's profit margin?

In FY2025, gross margin was 60.1%, operating margin 16.2%, and net margin 10.5%.

What is CL's P/E ratio?

Colgate-Palmolive's P/E (TTM) is 37.72 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CL stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 36.3× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.